Pfizer Plans to Seek Booster Approval for 16- and 17-Year-Olds

Pfizer Plans to Seek Booster Approval for 16- and 17-Year-Olds

Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds. Read full article here

Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds.

Read full article here

admin
ADMINISTRATOR
PROFILE

Posts Carousel

Leave a Comment

Your email address will not be published. Required fields are marked with *